Office of the Director; Notice of Meeting, 29297-29298 [2017-13573]
Download as PDF
<![CDATA[
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 123 / Wednesday, June 28, 2017 / Notices
foundational principles. Every 10 years,
through the Healthy People initiative,
HHS leverages scientific insights and
lessons from the past decade along with
new knowledge of current data, trends,
and innovations to develop the next
iteration of national health promotion
and disease prevention objectives.
Healthy People provides science-based,
10-year national objectives for
promoting health and preventing
disease. Since 1979, Healthy People has
set and monitored national health
objectives to meet a broad range of
health needs, encouraged collaborations
across sectors, guided individuals
toward making informed health
decisions, and measured the impact of
our prevention and health promotion
activities. Healthy People 2030 will
reflect assessments of major risks to
health and wellness, changing public
health priorities, new knowledge in
prevention, and emerging issues related
to our nation’s health preparedness.
DATES: In order for comments on the
proposed vision, mission, overarching
goals, and framework for Healthy People
2030 to be considered, written
comments must be submitted via the
Internet at www.HealthyPeople.gov by
5:00 p.m. Eastern Time on September
29, 2017.
ADDRESSES: The proposed framework
for Healthy People 2030 can be viewed
and commented upon at https://
www.healthypeople.gov.
FOR FURTHER INFORMATION CONTACT:
Ayanna Johnson, Public Health Advisor,
U.S. Department of Health and Human
Services, Office of the Assistant
Secretary for Health, Office of Disease
Prevention and Health Promotion, 1101
Wootton Parkway, Suite LL100,
Rockville, MD 20852, HP2030@hhs.gov
(email), or (240) 245–8281 (fax).
SUPPLEMENTARY INFORMATION:
Background: The Healthy People
development process strives to
maximize transparency, public input
and stakeholder dialogue to ensure that
Healthy People 2030 is relevant to
diverse public health needs and seizes
opportunities to achieve its goals. Since
its inception, Healthy People has
become a broad-based, public
engagement initiative with thousands of
citizens helping to shape it at every step
along the way. Drawing on the expertise
of a Secretary’s Advisory Committee on
National Health Promotion and Disease
Prevention Objectives for 2030 and
public input, Healthy People will be
organized to establish a framework to
address risk factors and determinants of
health and the diseases and disorders
that are affecting our communities.
Public participation will shape Healthy
VerDate Sep<11>2014
17:22 Jun 27, 2017
Jkt 241001
People 2030, its purpose, goals,
organization, and action plans. HHS is
soliciting written public comments on
the development of Healthy People 2030
through online public comment. As a
national initiative, Healthy People’s
success depends on a coordinated
commitment to improve the health of
the nation. Individuals may subscribe to
the listserv at: https://bit.ly/2g3tqdE for
the latest information on Healthy People
2020 and Healthy People 2030.
Authority: 42 U.S.C. 200u.
Dated: June 1, 2017.
Don Wright,
Deputy Assistant Secretary for Health,
Disease Prevention and Health Promotion.
[FR Doc. 2017–13463 Filed 6–27–17; 8:45 am]
29297
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: June 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13466 Filed 6–27–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4150–32–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Director; Notice of
Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the NIH
Clinical Center Research Hospital
Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The portion of the meeting devoted to
the identification and evaluation of
specific candidates for consideration for
a leadership position in the Clinical
Center will be closed to the public in
accordance with the provisions set forth
in section 552b(c)(9)(B) and 552b(c)(6),
Title 5 U.S.C., as amended. Premature
disclosure of potential candidates and
their qualifications, as well as the
discussions by the committee, could
significantly frustrate NIH’s ability to
recruit these individuals and the
consideration of personnel
qualifications, performance, and the
competence of individuals as candidates
would constitute a clearly unwarranted
invasion of personal privacy.
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Frederick National Laboratory Advisory
Committee to the National Cancer
Institute.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The discussion of research
projects/programs could disclose
unpublished and financial data,
technical information, confidential trade
secrets or commercial property, such as
patentable material, and personal
information concerning investigators/
individuals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Frederick National
Laboratory Advisory Committee to the
National Cancer Institute.
Date: July 18, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review the existing research
portfolio (both intramural and extramural)
and newly initiated research projects being
conducted at the Frederick National
Laboratory for Cancer Research (FNLCR).
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
TE406, Rockville, MD 20850 (Virtual
Meeting).
Contact Person: Caron A. Lyman, Ph.D.,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W–126,
Bethesda, MD 20892, 240–276–6348,
lymanc@mail.nih.gov.
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: July 14, 2017.
Open: 9:00 a.m. to 3:15 p.m.
Agenda: Clinical Protocol Prioritization;
Patient Safety Tracking; AAHRP 5 Year
Accreditation Process; Bioethics; Report on
CC Focus Groups.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Closed: 3:30 p.m. to 5:00 p.m.
E:\FR\FM\28JNN1.SGM
28JNN1
29298
Federal Register / Vol. 82, No. 123 / Wednesday, June 28, 2017 / Notices
Agenda: Identification of Candidates for
Leadership Role.
Place: National Institutes of Health,
Building 31, 6th Floor, Conference Room
6C6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: June 23, 2017.
Anna Snouffer
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13573 Filed 6–27–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Immune Disfunctions and
Pathologies.
Date: July 20, 2017.
Time: 1:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: David B. Winter, Ph.D.,
Scientific Review Officer, Center for
VerDate Sep<11>2014
18:05 Jun 27, 2017
Jkt 241001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4204,
MSC 7812, Bethesda, MD 20892, 301–435–
1152, dwinter@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Virology.
Date: July 25, 2017.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Neerja Kaushik-Basu,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3198,
MSC 7808, Bethesda, MD 20892, (301)435–
2306, kaushikbasun@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Bioengineering Sciences.
Date: July 25, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Craig Giroux, Ph.D.,
Scientific Review Officer, BST IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5150,
Bethesda, MD 20892, 301–435–2204,
girouxcn@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: GPCR and drugs of addiction.
Date: July 25, 2017.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Carol Hamelink, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4192,
MSC 7850, Bethesda, MD 20892, (301) 213–
9887, hamelinc@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: June 22, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–13465 Filed 6–27–17; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Integrative Research
in Gynecology Health.
Date: July 21, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Dennis E. Leszczynski,
Ph.D., Scientific Review, Administrator,
Division of Scientific Review, National
Institute of Child Health and Human
Development, NIH, 6710B Rockledge Drive,
Bethesda, MD, (301) 435–6884, leszczyd@
mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; NICHD Special
Emphasis Panel.
Date: August 1, 2017.
Time: 9:30 a.m. to 11:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Minki Chatterji, Scientific
Review Administrator, Division of Scientific
Review, National Institute of Child Health
and Human Development, NIH, 6710B
Rockledge Drive, Bethesda, MD,
301.827.5435, minki.chatterji@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Limb Loss and
Preservation Registry.
Date: August 8, 2017.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Sathasiva B. Kandasamy,
Ph.D., Scientific Review Administrator,
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 82, Number 123 (Wednesday, June 28, 2017)]
[Notices]
[Pages 29297-29298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-13573]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the NIH
Clinical Center Research Hospital Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The portion of the meeting devoted to the identification and
evaluation of specific candidates for consideration for a leadership
position in the Clinical Center will be closed to the public in
accordance with the provisions set forth in section 552b(c)(9)(B) and
552b(c)(6), Title 5 U.S.C., as amended. Premature disclosure of
potential candidates and their qualifications, as well as the
discussions by the committee, could significantly frustrate NIH's
ability to recruit these individuals and the consideration of personnel
qualifications, performance, and the competence of individuals as
candidates would constitute a clearly unwarranted invasion of personal
privacy.
Name of Committee: NIH Clinical Center Research Hospital Board.
Date: July 14, 2017.
Open: 9:00 a.m. to 3:15 p.m.
Agenda: Clinical Protocol Prioritization; Patient Safety
Tracking; AAHRP 5 Year Accreditation Process; Bioethics; Report on
CC Focus Groups.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.
Closed: 3:30 p.m. to 5:00 p.m.
[[Page 29298]]
Agenda: Identification of Candidates for Leadership Role.
Place: National Institutes of Health, Building 31, 6th Floor,
Conference Room 6C6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Gretchen Wood, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,,
Building 1, Room 126, Bethesda, MD 20892, 301-496-4272,
woodgs@od.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Dated: June 23, 2017.
Anna Snouffer
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-13573 Filed 6-27-17; 8:45 am]
BILLING CODE 4140-01-P
